Genome-wide DNA copy number analysis of desmoplastic infantile astrocytomas and desmoplastic infantile gangliogliomas

Journal of Neuropathology and Experimental Neurology

Volumn 72, Issue 9, 2013, Pages 807-815

  Gessi, Marco ^a   Mühlen, Anja Zur ^a   Hammes, Jennifer ^a   Waha, Andreas ^a   Denkhaus, Dorota ^a   Pietsch, Torsten ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

BRAF; Desmoplastic infantile astrocytoma; Desmoplastic infantile ganglioglioma; Molecular inversion probe analysis; Multiplex ligation dependent probe amplification

Indexed keywords

B RAF KINASE; GLUTAMIC ACID; SCATTER FACTOR RECEPTOR; VALINE;

ARTICLE; ASTROCYTOMA; CANCER TISSUE; CHILD; CHILDHOOD CANCER; CHROMOSOME 10Q; CHROMOSOME 21Q; CHROMOSOME 4Q; CHROMOSOME 5Q; CONTROLLED STUDY; DESMOPLASTIC INFANTILE ASTROCYTOMA; DESMOPLASTIC INFANTILE GANGLIOGLIOMA; FEMALE; GAIN OF FUNCTION MUTATION; GENE CLUSTER; GENE DOSAGE; GENE LOSS; GENETIC ASSOCIATION; GENOME ANALYSIS; GLIOMA; HUMAN; HUMAN TISSUE; INFANT; MALE; MOLECULAR PROBE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PRESCHOOL CHILD; PRIORITY JOURNAL;

ASTROCYTOMA; BRAIN NEOPLASMS; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; DNA COPY NUMBER VARIATIONS; FEMALE; GANGLIOGLIOMA; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFANT; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PRINCIPAL COMPONENT ANALYSIS; PROTO-ONCOGENE PROTEINS B-RAF;

EID: 84883600896     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3182a033a0     Document Type: Article

References (27)

1. Louis DN, Ohgaki H, Wiestler OD, et al. WHO Classification of Tumours of the Central Nervous System. Lyon, France: IARC Press; 2007
2. Rodriguez FJ, Lim KS, Bowers D, et al. Pathological and molecular advances in pediatric low-grade astrocytoma. Annu Rev Pathol 2013;8: 361-79
3. Brat DJ, VanderBerg SR, Figarella-Branger D, et al. Desmoplastic infantile astrocytoma and ganglioglioma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumours of the Central Nervous System. Lyon, France: IARC Press; 2007:96-98
4. Schindler G, Capper D, Meyer J, et al. Analysis of BRAFV600E mutation in 1320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extracerebellar pilocytic astrocytoma. Acta Neuropathol 2011;121:397-405
5. Dougherty MJ, Santi M, Brose MS, et al. Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. Neuro Oncol 2010;12:621-30
6. Hummel TR, Miles L, Mangano FT, et al. Clinical heterogeneity of desmoplastic infantile ganglioglioma: A case series and literature review. J Pediatr Hematol Oncol 2012;34:232-36
7. Wang Y, Cottman M, Schiffman JD. Molecular inversion probes: A novel microarray technology and its application in cancer research. Cancer Genet 2012;205:341-55
8. Jahromi MS, Putnam AR, Druzgal C, et al. Molecular inversion probe analysis detects novel copy number alterations in Ewing sarcoma. Cancer Genet 2012;205:391-404
9. Hömig-Hölzel C, Savola S. Multiplex ligation-dependent probe amplification (MLPA) in tumor diagnostics and prognostics. Diagn Mol Pathol 2012;21:189-206
10. Packham D, Ward RL, Ap Lin V, et al. Implementation of novel pyrosequencing assays to screen for common mutations of BRAF and KRAS in a cohort of sporadic colorectal cancers. Diagn Mol Pathol 2009;18:62-71
11. Milanaccio C, Nozza P, Ravegnani M, et al. Cervico-medullary desmoplastic infantile ganglioglioma: An unusual case with diffuse leptomeningeal dissemination at diagnosis. Pediatr Blood Cancer 2005;45:986-90
12. Cerdá-Nicolás M, Lopez-Gines C, Gil-Benso R, et al. Desmoplastic infantile ganglioglioma: Morphological, immunohistochemical and genetic features. Histopathology 2006;81:617-21
13. Louis DN, von Deimling A, Dickersin GR, et al. Desmoplastic cerebral astrocytomas of infancy: A histopathologic, immunohistochemical, ultrastructural, and molecular genetic study. Hum Pathol 1992;23:1402-9
14. Lönnrot K, Terho M, Kähärä V, et al. Desmoplastic infantile ganglioglioma: Novel aspects in clinical presentation and genetics. Surg Neurol 2007;68:304-8
15. Park JP, Dossu JR, Rhodes CH. Telomere associations in desmoplastic infantile ganglioglioma. Cancer Genet Cytogenet 1996;92:4-7
16. Kros JM, Delwel EJ, de Jong TH, et al. Desmoplastic infantile astrocytoma and ganglioglioma: A search for genomic characteristics. Acta Neuropathol 2002;104:144-48
17. Rodriguez FJ, Perry A, Gutmann DH, et al. Gliomas in neurofibromatosis type 1: A clinicopathologic study of 100 patients. J Neuropathol Exp Neurol 2008;67:240-49
18. Moldrich RX, Lainé J, Visel A, et al. Transmembrane protein 50b (C21orf4), a candidate for Down syndrome neurophenotypes, encodes an intracellular membrane protein expressed in the rodent brain. Neuroscience 2008;154: 1255-66
19. Sterrenberg JN, Blatch GL, Edkins AL. Human DNAJ in cancer and stem cells. Cancer Lett 2011;312:129-42
20. Paugh BS, Qu C, Jones C, et al. Molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 2010;28:3061-68
21. Gielen GH, Gessi M, Hammes J, et al. H3F3A K27M mutation in pediatric CNS tumors: A marker for diffuse high-grade astrocytomas. Am J Clin Pathol 2013;139:345-49
22. Hoving EW, Kros JM, Groninger E, et al. Desmoplastic infantile ganglioglioma with a malignant course. J Neurosurg Pediatr 2008;1:95-98
23. Kim YH, Nonoguchi N, Paulus W, et al. Frequent BRAF gain in lowgrade diffuse gliomas with 1p/19q loss. Brain Pathol 2012;22:834-40
24. Motomura K, Mittelbronn M, Paulus W, et al. PDGFRA gain in lowgrade diffuse gliomas. J Neuropathol Exp Neurol 2013;72:61-66
25. Caronia MA, Phay JE, Shah MH. Role of BRAF in thyroid oncogenesis. Clin Cancer Res 2011;17:7511-17
26. Myung JK, Cho H, Park CK, et al. Analysis of the BRAF (V600E) mutation in central nervous system tumors. Transl Oncol 2012;5: 430-36
27. Dias-Santagata D, Lam Q, Vernovsky K, et al. BRAFV600E mutations are common in pleomorphic xanthoastrocytoma: Diagnostic and therapeutic implications. PLoS ONE 2011;6:7948